theory clinical_104_1
imports Main

begin

typedecl entity
typedecl event

consts
  Inhibitor :: "entity ⇒ bool"
  Irreversible :: "entity ⇒ bool"
  TargetedTo :: "entity ⇒ entity ⇒ bool"
  HER2_Kinase_Domain :: "entity ⇒ bool"
  Overcome :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Trastuzumab_Resistance :: "entity ⇒ bool"
  InducedBy :: "entity ⇒ event ⇒ bool"
  HER2_Activating_Mutation :: "event ⇒ bool"
  HER2_V777L :: "entity ⇒ bool"
  Trastuzumab :: "entity ⇒ bool"
  Extracellular_Kinase_Domain :: "entity ⇒ bool"
  Intracellular_Kinase_Domain :: "entity ⇒ bool"
  Cause :: "event ⇒ bool"
  Resistance :: "event ⇒ entity ⇒ bool"
  Bind :: "event ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  Targeting :: "entity ⇒ bool"
  HER_V777L_Mutation :: "entity ⇒ bool"
  Tyrosine_Kinase_Inhibitor :: "entity ⇒ bool"

(* Explanation 1: An irreversible inhibitor that is targeted to the HER2 kinase domain should overcome trastuzumab resistance that has been induced by a HER2-activating mutation. *)
axiomatization where
  explanation_1: "∃x y z e1 e2. Inhibitor x ∧ Irreversible x ∧ TargetedTo x y ∧ HER2_Kinase_Domain y ∧ Overcome e1 ∧ Agent e1 x ∧ Trastuzumab_Resistance z ∧ InducedBy z e2 ∧ HER2_Activating_Mutation e2"

(* Explanation 2: HER2 V777L may cause resistance to trastuzumab, as trastuzumab binds to the extracellular kinase domain, whereas the mutation is in the intracellular kinase domain. *)
axiomatization where
  explanation_2: "∃x y z e1 e2. HER2_V777L x ∧ Trastuzumab y ∧ Extracellular_Kinase_Domain z ∧ Intracellular_Kinase_Domain z ∧ Cause e1 ∧ Agent e1 x ∧ Resistance e1 y ∧ Bind e2 ∧ Agent e2 y ∧ Patient e2 z ∧ In x z"

(* Explanation 3: Targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor can overcome the resistance caused by the HER2 V777L mutation. *)
axiomatization where
  explanation_3: "∃x y z e1 e2. Targeting x ∧ HER_V777L_Mutation y ∧ Tyrosine_Kinase_Inhibitor x ∧ Irreversible x ∧ Overcome e1 ∧ Agent e1 x ∧ Resistance e1 z ∧ Cause e2 ∧ Agent e2 y ∧ Patient e2 z"

theorem hypothesis:
  assumes asm: "HER_V777L_Mutation y ∧ Tyrosine_Kinase_Inhibitor x ∧ Irreversible x"
  (* Hypothesis: Targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance. *)
  shows "∃x y e. Targeting x ∧ HER_V777L_Mutation y ∧ Tyrosine_Kinase_Inhibitor x ∧ Irreversible x ∧ Overcome e ∧ Agent e x ∧ Patient e y ∧ Treatment_Resistance y"
proof -
  (* From the premise, we have the known information about HER_V777L_Mutation, Tyrosine_Kinase_Inhibitor, and Irreversible. *)
  from asm have "HER_V777L_Mutation y ∧ Tyrosine_Kinase_Inhibitor x ∧ Irreversible x" by blast
  (* Explanation 3 provides a logical relation Implies(F, G), which states that targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor can overcome the resistance caused by the HER2 V777L mutation. *)
  (* Since we have HER_V777L_Mutation y, Tyrosine_Kinase_Inhibitor x, and Irreversible x, we can infer the existence of an event e that satisfies the hypothesis. *)
  then have "∃e. Targeting x ∧ Overcome e ∧ Agent e x ∧ Patient e y ∧ Treatment_Resistance y" sledgehammer
  then show ?thesis <ATP>
qed

end
